These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11872566)
1. Demand for prostate specific antigen testing in primary care. Screening through back passage as well as back door? Hopcroft K BMJ; 2002 Mar; 324(7336):547. PubMed ID: 11872566 [No Abstract] [Full Text] [Related]
2. Prostate cancer screening--is the controversy resolved? Norcross WA; Ganiats TG West J Med; 1995 Jul; 163(1):65-6. PubMed ID: 7545340 [No Abstract] [Full Text] [Related]
3. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed]. Bratt O; Björk T Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615 [No Abstract] [Full Text] [Related]
5. Demand for prostate specific antigen testing in primary care. Can the demand for PSA testing in primary care be managed? Singh Kalsi G BMJ; 2002 Mar; 324(7336):547. PubMed ID: 11876180 [No Abstract] [Full Text] [Related]
6. New tests for prostate cancer may be nearing the clinic. Tuma RS J Natl Cancer Inst; 2010 Jun; 102(11):752-4. PubMed ID: 20498428 [No Abstract] [Full Text] [Related]
7. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia]. Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV Urologiia; 2001; (2):37-40. PubMed ID: 11490716 [TBL] [Abstract][Full Text] [Related]
9. Application of prostate-specific antigen in prostate cancer. Liang SL MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558 [No Abstract] [Full Text] [Related]
10. Prostate specific antigen and screening for early prostate cancer. Davidson P N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919 [No Abstract] [Full Text] [Related]
11. Weighing the benefits and downsides of prostate-specific antigen screening. Pignone M Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672 [No Abstract] [Full Text] [Related]
12. Early detection of prostate cancer. Role of prostate-specific antigen. Prabhakaran VM Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039 [TBL] [Abstract][Full Text] [Related]
13. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment]. Pushkar' DIu; Rasner PI; Skobelev PP Urologiia; 2001; (6):48-54. PubMed ID: 11785083 [No Abstract] [Full Text] [Related]
17. Prostate-specific antigen and prostate cancer prognosis. Church TR J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347 [No Abstract] [Full Text] [Related]
18. [The prostate specific antigen: what can we learn from the American experience?]. Zhao XJ Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833 [No Abstract] [Full Text] [Related]
19. Prostate-specific antigen and screening for prostate cancer. Han M; Gann PH; Catalona WJ Med Clin North Am; 2004 Mar; 88(2):245-65, ix. PubMed ID: 15049577 [TBL] [Abstract][Full Text] [Related]
20. Is a screening interval of every 4 years for prostate cancer acceptable? Crawford ED J Natl Cancer Inst; 2007 Sep; 99(17):1279-80. PubMed ID: 17728212 [No Abstract] [Full Text] [Related] [Next] [New Search]